Interview: Start-Up Phase is a Prime Target for Virtual Activities in Clinical Trials, So Let’s Adapt
Before 2020 “virtual clinical trials” was just a buzzword. Now we’re forced to adapt. But what challenges – and opportunities – are ahead?
Guessing could be adding 7 months of clinical trial delays. Here’s how to stop.
Getting new treatments approved has never been harder, but recent research reveals that the regulatory agency has also never been faster. So why is it getting more expensive and taking ever longer to bring a treatment to market? Three words: Clinical trial delays.
It’s taking longer to bring a treatment to
Can a Remote Investigator Meeting Be Effective? Yes, and Here’s How
As COVID-19 continues to impact us, principle investigator meetings are off the table. Or are they? Yes, you can pull off an effective, virtual investigator meeting for your clinical trial. Here’s how to make sure you do.
Infographic: The Impact of Clinical Trial Readiness on Trial Team Performance
Implementing clinical trial readiness enables you to confidently predict who will succeed in conducting your clinical trial – and who needs more preparation.
5 Places in Clinical Trials Where You Should Be Digital Now
Until the recent changes forced upon our industry by COVID-19, clinical research has been anything but digital: instead, relying heavily on in-person interaction, monitoring, and data collection.
Many trials have been forced to halt, or change standard operating procedures (SOPs) in order to restart. The adoption of digital solutions has accelerated.
3 Metrics You Need to Add to Your Clinical Trial Site Selection Checklist
You’re using the clinical trial site selection checklist you’ve always used, but you’re still struggling with the same delays, site problems, and retraining you see in every trial. Why? It’s time to adjust the way you measure your sites for selection.
7 Areas That Should Be Optimized to Achieve Clinical Trial Readiness
Read this excerpt from our eBook.
Interview: Adopting Consumer Tech in Clinical Trials Will Pave the Way for Hybrid and Virtual Trials
We recently spoke with Kemi Olugemo, M.D., Executive Medical Director, Neurology Clinical Development at Akcea Therapeutics. Akcea is a development and commercialization company focused on helping patients with serious diseases. The company is based in Boston, MA. Here are some of the most interesting excerpts from our discussion:
ArcheMedX:
You’re a neurologist
Why Does Clinical Trial Readiness Matter, and How is it Used to Improve Performance?
Clinical trial readiness is an essential part of keeping the many people who participate in clinical trials safe while ensuring the trial runs smoothly, remains in compliance, and stays within budget.
ArcheMedX Stands with Those Advancing True, Meaningful Equality for All
We join our partners in celebrating Pride Month, because LGBTQ+ rights are human rights. ArcheMedX will always stand with the LBGTQ+ community, with Black Lives Matter, and with anyone who seeks to advance true, meaningful Equality for all. Read our statement in support of Pride Month here.
